End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry

Published:2009-10-21 Issue:3 Volume:25 Page:769-775
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Ortiz A.,Cianciaruso B.,Cizmarik M.,Germain D. P.,Mignani R.,Oliveira J. P.,Villalobos J.,Vujkovac B.,Waldek S.,Wanner C.,Warnock D. G.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/25/3/769/5392351/gfp554.pdf

Reference23 articles.

1. Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry

2. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy

3. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

4. Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease

5. Enzyme Replacement Therapy in Fabry Disease

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of podocyte injury in the pathogenesis of Fabry disease nephropathy;Brazilian Journal of Nephrology;2024-09

2. O papel da injúria podocitária na patogênese da nefropatia da doença de Fabry;Brazilian Journal of Nephrology;2024-09

3. Reduction in kidney function decline and risk of severe clinical events in agalsidase beta–treated Fabry disease patients: a matched analysis from the Fabry Registry;Clinical Kidney Journal;2024-07-02

4. A Systematic Review on Safety and Efficacy of Migalastat for the treatment of Fabry’s Disease;Expert Opinion on Pharmacotherapy;2024-04-12

5. Interaction of Fabry Disease and Diabetes Mellitus: Suboptimal Recruitment of Kidney Protective Factors;International Journal of Molecular Sciences;2023-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3